In a symposium beginning Monday at 3:15 p.m. PT in Ballroom 6A-B, principal Investigator John Kirwan, MSc, PhD, will present ARMMS-T2D study results comparing surgery versus medical and lifestyle intervention in patients with type 2 diabetes, as well as long-term effects post-surgery. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Coming up: Is Metabolic Surgery or Lifestyle/Medical Management of Type 2 Diabetes Optimal for Long-Term Health? Long-Term Outcomes of the ARMMS-T2D Randomized Trial after 7-12 Years of Follow-Up
